Study of efficacy and safety of apatinib in patients with advanced synovial sarcoma
Latest Information Update: 20 Jun 2018
At a glance
- Drugs Rivoceranib (Primary)
- Indications Synovial sarcoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 20 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology